# FDA Inspection 576047 - Bonfils Blood Center - Sterling - March 31, 2009

Source: https://www.keypedia.com/records/fda_inspections/bonfils-blood-center-sterling/5babd527-e1e4-43af-96fe-8307c0df8821
Source feed: FDA_Inspections

> FDA Inspection 576047 for Bonfils Blood Center - Sterling on March 31, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 576047
- Company Name: Bonfils Blood Center - Sterling
- Inspection Date: 2009-03-31
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 755781 - 2011-12-01](https://www.keypedia.com/records/fda_inspections/bonfils-blood-center-sterling/018a9c64-59df-4135-906c-fc008dc78d83)
- [FDA Inspection 658065 - 2010-04-15](https://www.keypedia.com/records/fda_inspections/bonfils-blood-center-sterling/06498c93-1dd0-47ca-ac1a-5402c686ed52)

Company: https://www.keypedia.com/companies/bonfils-blood-center-sterling/60565cd3-827a-4c50-bfef-2057a3dab180

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d